Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report. // Academic Pediatrics. – URL: https://www.sciencedirect.com/science/article/pii/S3050915726002717?dgcid=rss_sd_all
Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report. Academic Pediatrics. https://www.sciencedirect.com/science/article/pii/S3050915726002717?dgcid=rss_sd_all
“Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report.” Academic Pediatrics.
@article{article2367,
title = {Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report},
journal = {Academic Pediatrics},
url = {https://www.sciencedirect.com/science/article/pii/S3050915726002717?dgcid=rss_sd_all}
}
Publication date: Available online 14 November 2026 Source: AACE Endocrinology and Diabetes Author(s): Laura Pierotti, Chiara Sardella, Simone Della Valentina, Anna Dal Lago, Giacomo De Leo, Filomena Cetani